drugset / Trial / NCT01848210
Efficacy and Safety of Coumarin and Troxerutin in the Symptomatic Treatment of Chronic Venous Insufficiency
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of the fixed-dose combination of coumarin and troxerutin versus placebo in the symptomatic treatment of chronic venous insufficiency.
Timeline
- Start
- 2013-05
- Primary completion
- 2015-09
- Completion
- 2015-09
Outcome
Missed primary endpoint
registry analysis (superiority or other test); Coumarin + Troxerutin vs Placebo; p = 0.531; Mean Difference (Final Values) -4.65 (95% CI -19.81 to 10.51); Regression, Linear NCT01848210 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Coumarin | Small molecule | 30 mg | Oral |
| Subject | Troxerutin | Small molecule | 180 mg | Oral |